Drug Monograph
Full clinical overview, indications, dosage references & safety notes.
Overview
Dexmedetomidine (Dexdomitor®, Sedadex®, Sileo®) is a potent alpha-2 adrenergic agonist used in dogs and cats for sedation, premedication, and analgesia. It produces dose-dependent sedation, muscle relaxation, and analgesia, and is commonly used alone or in combination with other agents such as opioids.
It is the active dextroenantiomer of medetomidine and is approximately twice as potent, allowing for lower doses and potentially smoother recoveries. It is widely used in anesthesia protocols and can be reversed with atipamezole to shorten recovery time.
Mechanism of Action (MOA): Dexmedetomidine stimulates central and peripheral alpha-2 adrenergic receptors, leading to decreased sympathetic outflow, resulting in sedation, analgesia, and muscle relaxation. It also causes characteristic cardiovascular effects, including initial vasoconstriction with hypertension followed by reflex bradycardia and reduced cardiac output.
Indications
Dexmedetomidine is widely used in dogs and cats for sedation, analgesia, and as part of anesthetic protocols, as well as for behavioral management in specific situations.
- Sedation and premedication: Used alone or in combination (commonly with opioids) to provide sedation and facilitate handling, diagnostic procedures, or anesthesia.
- Short-term anesthesia (cats): In combination with ketamine, provides short-duration surgical anesthesia (approximately 20–30 minutes).
- Perioperative analgesia: Used as part of multimodal analgesic protocols, including constant rate infusion (CRI) for ongoing pain control.
- Emergence excitation: Low doses may be used to manage agitation during recovery from anesthesia.
Dosage (Reference)
Dog
In dogs, dexmedetomidine dosing varies depending on indication and is typically used in combination with other drugs to enhance sedation and analgesia while minimizing adverse effects.
| Clinical use | Route | Dose | Notes |
|---|---|---|---|
| Noise anxiety | Oral gel (buccal) | 125 µg/m² | Apply 30–60 min before noise or at onset; may repeat after 2–3 hours. |
| Premedication (with opioid) | IV / IM / SC | 2–10 µg/kg | Use lower end for IV dosing. |
| Emergence excitation | IV | 1 µg/kg | May prolong recovery; monitor closely. |
| Analgesia / CRI | IV infusion | 1–2 µg/kg/hour | Often combined with opioids for improved analgesia. |
• Lower doses (1–10 µg/kg) are preferred to reduce cardiovascular effects.
• Higher doses (>10 µg/kg) are associated with greater physiologic disturbances.
• Combining with opioids allows dose reduction and improves sedation/analgesia.
• Analgesia duration after ~5 µg/kg dose is approximately 1 hour.
• Reversal with atipamezole shortens recovery time.
Cat
In cats, dexmedetomidine is commonly used as part of sedation and anesthesia protocols, often in combination with other agents such as opioids or ketamine.
| Clinical use | Route | Dose | Notes |
|---|---|---|---|
| Premedication (with opioid) | IV / IM / SC | 2–10 µg/kg | Commonly used in combination protocols. |
| Emergence excitation | IV | 1 µg/kg | May prolong recovery; monitor closely. |
| Analgesia / CRI | IV infusion | 1–2 µg/kg/hour | Adjunct to opioid analgesia for improved effect. |
• Typically used as part of combination protocols (e.g., with ketamine or opioids).
• Lower doses help minimize cardiovascular depression.
• Provides reliable sedation and short-duration anesthesia when combined appropriately.
• Recovery can be shortened with atipamezole reversal.
Warnings & Precautions
Dexmedetomidine produces significant cardiovascular and physiologic effects and should be used with careful patient selection and monitoring.
- Cardiovascular disease: Contraindicated in patients with cardiovascular or significant systemic disease due to marked effects on heart rate, blood pressure, and cardiac output.
- Geriatric patients: Use is not recommended due to increased sensitivity and risk of adverse effects.
- Pregnancy: Should not be used in pregnant animals.
- Sympathomimetic drugs: Avoid use in animals receiving or likely to require sympathomimetic amines.
- Vomiting risk: Common after IM administration; avoid in patients where vomiting is contraindicated (e.g., GI obstruction, increased intraocular pressure).
- Diabetes mellitus: Not recommended due to effects on blood glucose (decreased insulin release and transient hyperglycemia).
- Respiratory support: Although ventilation is generally maintained, oxygen supplementation is recommended during sedation.
- Arousal with stimulation: Sedation may be overridden by strong stimuli; handle sedated animals cautiously.
Drug Interactions
Specific drug interaction data for dexmedetomidine in veterinary patients are limited. However, it is commonly used in combination with other anesthetic and analgesic agents, requiring dose adjustments and careful monitoring.
- No specific interactions reported: No well-documented drug–drug interactions were identified in the source.
Side Effects & Overdose
Side Effects
Adverse effects of dexmedetomidine in dogs and cats are primarily related to its cardiovascular, endocrine, and gastrointestinal effects, and are dose-dependent.
- Cardiovascular effects: Initial hypertension followed by bradycardia and reduced cardiac output due to peripheral vasoconstriction and central sympatholysis.
- Vomiting: Common after IM administration; may limit use in certain patients.
- Diuresis: Increased urine production due to suppression of ADH secretion.
- Hyperglycemia: Transient increase in blood glucose due to decreased insulin secretion.
- Mydriasis and decreased intraocular pressure: Ocular effects may be observed.
- Respiratory changes: Decreased respiratory rate with increased depth of respiration.
- Paradoxical arousal: Sudden awakening or responsiveness to stimulation may occur despite sedation.
Overdose
Overdose of dexmedetomidine results in exaggerated pharmacologic effects, particularly cardiovascular depression. Management is supportive, and reversal may be considered.
- Severe bradycardia: Marked reduction in heart rate.
- Profound cardiovascular depression: Significant decrease in cardiac output.
- Prolonged sedation: Extended duration of CNS depression.
- Management: Supportive care with monitoring of cardiovascular and respiratory function.
- Reversal agent: Atipamezole can be used to reverse effects and shorten recovery.
Key Notes
Practical clinical insights to optimize the use of dexmedetomidine in dogs and cats:
- Highly titratable sedation: Wide dosing range allows tailoring depth of sedation to procedure requirements.
- Opioid synergy: Combining with opioids significantly enhances both sedation and analgesia while reducing required doses.
- Short procedural use: Well suited for short procedures due to relatively brief analgesic duration.
- Reversible protocol advantage: Ability to reverse effects provides better control over recovery and patient turnover.
- CRI utility: Low-dose infusions are increasingly used for balanced anesthesia and smoother perioperative management.
Calculate Any Dose Instantly
Use our smart dose calculator to get accurate dosing for 500+ veterinary drugs — adjusted for species, weight, and route.
